Prostatis Group’s Main Street Capital MAIN Stock Holding History

Prostatis Group’s Portfolio MAIN Stock Details MAIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20,335	Closed	-$20.3K	–	182
2023 Q2	$20.3K	Buy	+20,335	New	+$807K	0.01%	227

Other funds holding MAIN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.07B AUM 4.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Prostatis Group's MAIN Position: Q3 2023 in Review

Prostatis Group sold out of Main Street Capital (MAIN) in Q3 2023, closing a stake of 20,335 shares — an estimated $20.3K sold.

Prostatis Group first reported a position in MAIN in Q2 2023 and held it in 1 quarter. The position peaked at $20.3K in Q2 2023. 292 funds tracked by Wall St. Rank hold MAIN as of Q3 2023.

Prostatis Group reported no remaining Main Street Capital position as of Q3 2023 after selling out during the quarter.
Prostatis Group sold 20,335 Main Street Capital shares in Q3 2023, an estimated $20.3K.
Prostatis Group first reported a position in Main Street Capital in Q2 2023 and held it in 1 quarter.
Prostatis Group's Main Street Capital position peaked at $20.3K in Q2 2023.
292 funds tracked by Wall St. Rank held Main Street Capital as of Q3 2023.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.